VOLITIONRX LTD — Director's Dealing 2019

Dec 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2019-12-16

Reporting Person: Vanston David Cecil (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-16	Option (Right to Buy)	$5	D	66533	Disposed	2023-04-10	Common Stock (100000)	Direct
2019-12-16	Option (Right to Buy)	$5	A	66533	Acquired	2023-04-10	Common Stock (66533)	Direct

Footnotes

F1: The reported transactions involved a cancellation and reissuance of a portion of outstanding options upon agreement of the reporting person. The "old" options were originally granted on April 10, 2017 and vested in full at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested on the date of grant and have the same expiration date and exercise price as the "old" options.